J Falloon

1.4k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

J Falloon is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, J Falloon has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in J Falloon's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). J Falloon is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). J Falloon collaborates with scholars based in United States. J Falloon's co-authors include Kirk D. Miller, Elizabeth C. Jones, Irwin M. Feuerstein, Jack A. Yanovski, Richard T. Davey, Joseph A. Kovacs, Michael A. Polis, Barbara Baird, Robert Walker and Kathryn M. Zunich and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and The Journal of Infectious Diseases.

In The Last Decade

J Falloon

8 papers receiving 1.0k citations

Hit Papers

Visceral abdominal-fat accumulation associated with use o... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Falloon United States 7 508 454 430 400 123 9 1.1k
Antonio Chirianni Italy 17 429 0.8× 553 1.2× 444 1.0× 292 0.7× 10 0.1× 70 1.1k
Beverly Alston‐Smith United States 13 281 0.6× 421 0.9× 610 1.4× 329 0.8× 19 0.2× 23 1.0k
P. de Truchis France 10 251 0.5× 351 0.8× 147 0.3× 201 0.5× 27 0.2× 20 589
George McKinley United States 12 219 0.4× 227 0.5× 39 0.1× 389 1.0× 60 0.5× 28 644
J Beylot France 18 137 0.3× 321 0.7× 145 0.3× 239 0.6× 8 0.1× 98 984
Pierre de Truchis France 19 582 1.1× 653 1.4× 463 1.1× 276 0.7× 5 0.0× 42 1.1k
Laurence Moachon France 10 123 0.2× 305 0.7× 142 0.3× 126 0.3× 20 0.2× 19 587
JL Pellegrin France 13 89 0.2× 220 0.5× 187 0.4× 186 0.5× 16 0.1× 52 733
Peter Gute Germany 18 688 1.4× 868 1.9× 216 0.5× 308 0.8× 4 0.0× 35 1.2k
Alaka Deshpande India 14 333 0.7× 387 0.9× 39 0.1× 210 0.5× 49 0.4× 52 702

Countries citing papers authored by J Falloon

Since Specialization
Citations

This map shows the geographic impact of J Falloon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Falloon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Falloon more than expected).

Fields of papers citing papers by J Falloon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Falloon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Falloon. The network helps show where J Falloon may publish in the future.

Co-authorship network of co-authors of J Falloon

This figure shows the co-authorship network connecting the top 25 collaborators of J Falloon. A scholar is included among the top collaborators of J Falloon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Falloon. J Falloon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kovacs, Joseph A., Susan Vogel, Randy Stevens, et al.. (2001). Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. European Journal of Immunology. 31(5). 1351–1360. 48 indexed citations
3.
Miller, Kirk D., et al.. (1998). Visceral abdominal-fat accumulation associated with use of indinavir. The Lancet. 351(9106). 871–875. 558 indexed citations breakdown →
4.
Kovacs, Joseph A., Richard T. Davey, J Falloon, et al.. (1996). Combination Therapy with Didanosine and Interferon-a in Human Immunodeficiency Virus-Infected Patients: Results of a Phase I/II Trial. The Journal of Infectious Diseases. 173(4). 840–848. 22 indexed citations
5.
Vasudevachari, M. B., et al.. (1996). Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection. Antimicrobial Agents and Chemotherapy. 40(11). 2535–2541. 23 indexed citations
6.
Polis, Michael A., Barbara Baird, Jody Manischewitz, et al.. (1995). Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrobial Agents and Chemotherapy. 39(4). 882–886. 97 indexed citations
7.
Zunich, Kathryn M., H. Clifford Lane, Richard T. Davey, et al.. (1992). Phase I/II Studies of the Toxicity and Immunogenicity of Recombinant gp160 and p24 Vaccines in HIV-Infected Individuals. AIDS Research and Human Retroviruses. 8(8). 1335–1335. 6 indexed citations
8.
Falloon, J. (1992). Current therapy for HIV infection and its infectious complications. Postgraduate Medicine. 91(8). 115–132.
9.
Palestine, Alan G., Michael A. Polis, Marc D. de Smet, et al.. (1991). A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS. Annals of Internal Medicine. 115(9). 665–673. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026